iOS app Android app

Gleevec

CML Is Not Yet Cured: Reaction to the #OneDown Campaign

Erin Havel | Posted 07.11.2014 | Impact
Erin Havel

The word cure evokes powerful images of treatments ending, and a survivor stepping away from the carnage to begin a new life. It is the hope many cancer patients reach for. This is why OHSU sparked outrage this week when they began their One Down Campaign.

Five Things I've Learned From a Pioneering Cancer Geneticist

Katie Scarlett Brandt | Posted 03.10.2014 | Science
Katie Scarlett Brandt

Your passion itself might take immense effort, but doing it will energize you. Especially for people just starting out, Janet said, "You're going to need patience."

The Cost of Cancer Drugs and Research

Erin Havel | Posted 06.09.2013 | Healthy Living
Erin Havel

In their Intellectual property case, the pharmaceutical company Novartis was asking to block a generic form of their cancer drug Gleevec from being created and sold by India. As a writer and also a person living with chronic myelogenous leukemia, I understand both sides of the battle.

Indian Drug Ruling Strikes a Blow for Free Enterprise

Dean Baker | Posted 06.08.2013 | Business
Dean Baker

The costs of protectionism can be large, as economists frequently point out when discussing 20 percent tariffs in steel. For some reason they become strangely silent when it comes to patent protection that raise the price of drugs by 1,000 percent.

Strong Medicine: Why India's Rejection of Drug Monopoly is a Lesson for America

Sanjay Sanghoee | Posted 06.03.2013 | Business
Sanjay Sanghoee

India is actually at the forefront of providing affordable medicine to its citizens, which is a vast improvement over the healthcare system in the US.

Novartis Loses Cancer Drug Patent Battle

AP | By NIRMALA GEORGE | Posted 05.31.2013 | Business

NEW DELHI (AP) — India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landma...

Clinical Trials: With Informed Samaritans, a Key Way to Advance Science and Medicine, Benefit Others -- and Receive Leading-Edge Therapies

Glenn D. Braunstein, M.D. | Posted 12.22.2012 | Los Angeles
Glenn D. Braunstein, M.D.

Thousands of clinical trials take place every day in this country and around the world as part of modern science's best attempt to find answers to medicine's most pressing questions.

A Battle Close To Home: Thirty Eight Years After Nixon's Declaration Of War

Diane Balma | Posted 11.17.2011 | Healthy Living
Diane Balma

Scientists know more than ever before about the mechanisms of cancer and how to stop its spread. Yet the new numbers we're seeing are victories in skirmishes, not battles.